BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch
Biogen’s Alzheimer’s Drug Could be Expensive Biogen (NASDAQ: BIIB) could price its Alzheimer’s drug, Lecanemab, developed along with Essai as high as $20,000 every year, Barron’s reported on Friday,…
Read more BIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch